develops and commercializes novel reagents for the scientific study of human biology and
disease and for the production of new diagnostic assays and potential therapies of such
diseases. These novel reagents include antibodies, gene and protein expression systems,
and arrays of various cells and tissues for use in studies of functional genomics. Areas
of biological interest at Imgenex include cancer, apoptosis (programmed cell death),
molecular signaling pathways, cellular aging, and metabolic and infectious diseases.